Nobilis Therapeutics
  • Home
  • Company
    • About
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • NBTX-001
    • Science behind NBTX-001
    • Clinical Development Program
    • Intellectual property
  • Inhalation Devices
    • Zephyrus™ Device
  • Contact Us
Select Page

Nobilis Therapeutics will present two abstracts at the 19th WPA World Congress of Psychiatry

by nobilistx | Jul 17, 2019 | Uncategorized | 0 comments

Nobilis Therapeutics is happy to announce that both of its submitted abstracts have been accepted to the Scientific Program at the 19th WPA World Congress of Psychiatry. The Congress is the official annual forum of the World Psychiatric Association that represents 140...

News

  • Nobilis Therapeutics Announces FDA Clearance of IND to Commence Phase 2b Trial of NBTX-001 Inhaler for Treatment of Posttraumatic Stress Disorder December 6, 2019
  • Nobilis Therapeutics’ NBTX-001 Showed Beneficial Effects in an Animal Model of Autism December 3, 2019
  • US Patent is Granted for Nobilis Therapeutics Invention On the Use of Noble Gases to Treat Complications of Pregnancy November 26, 2019
  • Nobilis Therapeutics published an article “Combining Xenon Inhalation With Trauma Memory Reactivation to Reduce Symptoms of Posttraumatic Stress Disorder: Case Report, Justification of Approach, and Review of the Literature” in Primary Care Companion For CNS Disorders September 20, 2019
  • US Patent Granted for Nobilis Therapeutics Invention Covering the Use of Xenon in ALS August 27, 2019

Recent Posts

  • Nobilis Therapeutics Announces FDA Clearance of IND to Commence Phase 2b Trial of NBTX-001 Inhaler for Treatment of Posttraumatic Stress Disorder
  • Nobilis Therapeutics’ NBTX-001 Showed Beneficial Effects in an Animal Model of Autism
  • US Patent is Granted for Nobilis Therapeutics Invention On the Use of Noble Gases to Treat Complications of Pregnancy
  • Nobilis Therapeutics published an article “Combining Xenon Inhalation With Trauma Memory Reactivation to Reduce Symptoms of Posttraumatic Stress Disorder: Case Report, Justification of Approach, and Review of the Literature” in Primary Care Companion For CNS Disorders
  • US Patent Granted for Nobilis Therapeutics Invention Covering the Use of Xenon in ALS

Recent Comments

    Archives

    • December 2019
    • November 2019
    • September 2019
    • August 2019
    • July 2019
    • January 2019
    • December 2018
    • August 2018
    • June 2018
    • May 2018
    • February 2018
    • January 2018
    • December 2017
    • October 2017
    • June 2017
    • May 2017
    • April 2016
    • March 2016
    • January 2016

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Facebook
    • Twitter
    • Google
    • RSS

    Designed by GO | Powered by GOs